A comprehensive analysis of Utah’s clinical AI sandbox programme reveals significant safety benefits from independent algorithmic oversight. Among 47 algorithms evaluated by a multidisciplinary review board from 2024 to 2026, post-implementation safety alerts decreased by 73% compared to algorithms deployed without formal oversight mechanisms. The study, published in Nature Medicine, compared outcomes across different regulatory pathways: traditional FDA approval (127 algorithms), state regulatory review (93 algorithms), the Utah sandbox model (47 algorithms), and unregulated deployments (27 algorithms). Beyond safety metrics, the sandbox identified previously undetected bias in 12 of the 47 reviewed algorithms, addressing disparities that could harm minority patient populations. Healthcare organisations utilising the sandbox framework reported accelerated clinical integration at 40% faster rates than standard timelines. These findings underscore the tangible value of structured independent review in mitigating implementation risks.
Was this article helpful?
